Jeffrey N. Meshulam
Präsident bei Profectus BioSciences, Inc.
Aktive Positionen von Jeffrey N. Meshulam
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Direktor/Vorstandsmitglied | - | - |
Präsident | 01.01.2013 | - | |
Geschäftsführer | 01.01.2005 | - |
Karriereverlauf von Jeffrey N. Meshulam
Ehemalige bekannte Positionen von Jeffrey N. Meshulam
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Corporate Officer/Principal | 01.01.1996 | 01.01.2004 |
Cellular Products, Inc.
Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Vorstandsvorsitzender | 01.01.1983 | 01.01.1996 |
Vorsitzender | 01.01.1996 | 01.01.1996 | |
Gründer | 01.01.1996 | 01.01.1996 | |
Präsident | - | 01.01.1996 | |
International Retrovirology Association | Corporate Officer/Principal | - | - |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Direktor/Vorstandsmitglied | - | - |
Northern Scientific, Inc. | Präsident | - | - |
Ausbildung von Jeffrey N. Meshulam
State University of New York at Buffalo | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
President | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Cellular Products, Inc.
Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Health Technology |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Consumer Services |
Northern Scientific, Inc. | |
International Retrovirology Association |
- Börse
- Insiders
- Jeffrey N. Meshulam
- Erfahrung